Press Release

Thrombin Market Size, Share, Development, Key Opportunity, Geographical Overview Forecast till 2026

Thrombin Market by Top Key Players: Pfizer Inc., Johnson & Johnson Services Inc. and more till 2026

The Global Thrombin Market is supported by the rising rate of thrombosis among individuals, all around. The fatal nature of thrombosis and use of thrombin to trump thrombosis is emphasized in Fortune Business Insights’ latest report, titled “Thrombin Market: Global Analysis, Insights and Forecasts, 2019-2026.”

Get Sample PDF Brochure @ https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/thrombin-market-100170

“Some of the Main Key Players Covered in the Report” THROMBIN MARKET

  • Pfizer Inc.
  • Johnson & Johnson Services Inc.
  • Baxter
  • Shanghai RAAS blood products co. Ltd.
  • Japan Blood Products Organization
  • Mochida Pharmaceutical Co.

In the report, Fortune Business Insights has briefed that an increasing emphasis on clinical trials of thrombin has boosted the global market, and it is estimated to expand at a CAGR of 4.1%. As of 2018, The Global Thrombin Market has valued at US$ 535.0 Mn, and the forecasted CAGR means that this market will be valued at around US$ 738.7 Mn by the end of 2025.

Browse Complete Report Details @ https://www.fortunebusinessinsights.com/industry-reports/thrombin-market-100170

“Key Segmentation”

By Product

  • Bovine Thrombin
  • Human Thrombin
  • Recombinant Thrombin

By Dosage Form

  • Powder Form
  • Solution Form

By End user

  • Hospitals
  • Diagnostics Centers & Clinics
  • Academics and Research Institutes

By Geography

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

“Widespread Applications of Thrombin to Boost Global Market”

The extent of blood losses in hemodialysis can lead to various disorders and may also prove fatal in some cases. Thus, bovine-derived thrombin is given huge emphasis and healthcare professionals have prioritized thrombin for treating hemorrhages. The thrombin market is therefore forecast to witness a high demand for bovine-derive thrombin in the coming years.

Thrombin has come a long way from its conventional use to stop bleeding in small cuts on body parts. Now, thrombin plays a major role in most of the surgeries, worldwide. The clinical efficiency of thrombin has led to its widespread use in the healthcare industry, a key factor enabling growth in the global thrombin market. Thrombin is vastly effective in facilitating surgical hemostasis. Over the years, human thrombin was replaced with bovine thrombin, due to its increased efficiency in surgical procedures.

Pfizer’s has emerged as the leading company, backed by high clinical efficiency of its product ‘Thrombin JMI’. Some other companies that are operating in the global thrombin market are Johnson & Johnson Services Inc., Shanghai RAAS Blood Products Co. Ltd., Japan Blood Products Organization, and Mochida Pharmaceutical Co.

“Recothrom to Emerge as The Most Widely Used Product Type”

Thrombosis can be caused due to mere sedentary lifestyle habits such as smoking and some other factors such as heart failures, aging and cancer. Thrombin inhibitors play a major part in delaying blood clotting. The healing properties of thrombin, along with its ability to minimize bleeding during surgical procedures has led to an increase in demand for thrombin over the years.

As surgical blood loss has been prioritized by surgeons and healthcare professionals worldwide, there is an increasing need for an efficient solution to minimize such severe losses. Recothrom was initially manufactured by a US-based company, ZymoGenetics. After involvement from Bayer Healthcare, Recothrom was later acquired by Baxter International. The 2018 acquisition of Recothrom by Baxter has proved fruitful to the overall market.

As of now, Recothrom is the only drug that has been clinically approved for commercial use as a recombinant thrombin brand. Furthermore, Recothrom finds applications in cases where standard surgical procedures such as suture or cautery are ineffective.

“More Trending Topics from Fortune Business Insights”

Pulse Oximeters Market Memristors Market: 2019 Global Industry Trends, Growth, Share, Size and 2025 Forecast Research Report

Diabetes Drugs Market 2019 Size, Revenue, Share and Global Trend By Drug Class, Diabetes Type and Geography Forecast 2026

Parkinson’s Disease Drugs Market Growth Insight, Share, Development Status, Regional Trends Forecast till 2026

Cardiac Rhythm Management (CRM) Devices Market Size, Regional Trend, Future Growth, Industry Demand, Future Plans by Forecast to 2026

Tags

Dale Martinez

Dale possesses an engineering degree in Electronics from the Georgia Institute of Technology. She is the sole contributor at the Healthcare IT column. Before opting to write, Dale worked at major firms such as Microsoft, Amazon, GE, Raytheon, and so on. She possesses vast knowledge about a variety of fields like IT, IoT, Telecommunications, Health Dialysis, photovoltaic, and many others. Dale is also a ballet dancer.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close